Russia's RDIF sovereign wealth fund said on Monday it had reached an agreement with India's Virchow Biotech to produce up to 200 million doses a year of the Sputnik V vaccine in India.
Follow Israel Hayom on Facebook and Twitter
RDIF said the transfer of technology needed to produce the vaccine would be completed in the second quarter of the year.



